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To identify non-transcription factor
regulators of epidermal differentiation,
Bhaduri et al. devised a network
approach called proximity analysis and
applied it to identify MPZL3 as a
mitochondrial protein required for
epidermal differentiation. MPZL3
promotes the enzymatic activity of
mitochondrial protein FDXR, and the
factors together regulate ROS-mediated
epidermal differentiation.
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Current gene expression network approaches
commonly focus on transcription factors (TFs),
biasing network-based discovery efforts away from
potentially important non-TF proteins.We developed
proximity analysis, a network reconstruction method
that uses topological constraints of scale-free,
small-world biological networks to reconstruct rela-
tionships in eukaryotic systems, independent of sub-
cellular localization. Proximity analysis identified
MPZL3 as a highly connected hub that is strongly
induced during epidermal differentiation. MPZL3
was essential for normal differentiation, acting down-
stream of p63, ZNF750, KLF4, and RCOR1, each of
which bound near the MPZL3 gene and controlled
its expression. MPZL3 protein localized tomitochon-
dria, where it interacted with FDXR, which was
itself also found to be essential for differentiation.
Together, MPZL3 and FDXR increased reactive
oxygen species (ROS) to drive epidermal differentia-
tion. ROS-induced differentiation is dependent upon
promotion of FDXR enzymatic activity by MPZL3.
ROS induction by the MPZL3 and FDXR mitochon-
drial proteins is therefore essential for epidermal
differentiation.
INTRODUCTION
Somatic differentiation requires the concurrent regulation of a
large number of genes that are necessary for the tissue-specific
functions of differentiated cells. Much of this regulation comes
from transcription factors that regulate gene expression,
silencing genes that maintain a proliferative cell-cycle state
and activating genes that are necessary for the cellular functions
characteristic of the differentiated tissue. However, only a frac-
tion of the genes that are induced during a somatic differentiation
program are nuclear factors, and recent work suggests that
differentiation processes, as well as disease-causing defects in444 Developmental Cell 35, 444–457, November 23, 2015 ª2015 Elsdifferentiation, may be also regulated beyond the nucleus,
including in the mitochondria, the lysosome, and the ribosome
(Kasahara and Scorrano, 2014; Settembre et al., 2013; Xu
et al., 2013; Xue and Barna, 2012). Understanding how these
levels of regulation interact with canonical nuclear gene regula-
tion processes can better illuminate how differentiation pro-
ceeds through feedback and feedforward loops and may
provide additional insight into treatments for congenital and
somatic diseases of deranged differentiation.
Gene expression network reconstruction is a commonly used
method of describing organism level systems (Herrga˚rd et al.,
2008; Tong et al., 2004), identifying key relationships that can
highlight regulators of a process (Carro et al., 2010), and delin-
eating cell types at a transcriptional level (Yang et al., 2013).
While the applications of network-based analyses are vast, cur-
rent network algorithms favor models of less complex organisms
such as Escherichia coli or networks with a bias toward known
transcription factors. The recent DREAM5 consortium analysis
of the highest performing, most used network reconstruction
algorithms highlighted that while combining the outputs from
multiple existing network algorithms improved upon the perfor-
mance of a single algorithm alone, the ability to reconstruct
known relationships fell significantly from in silico networks to
E. coli networks to eukaryotic Saccharomyces cerevisiae net-
works (Marbach et al., 2012). Additional deconvolution efforts
aimed to improve these metrics, but were only able to do so in
an incremental manner for eukaryotes (Feizi et al., 2013). There-
fore, significant challenges persist in using network reconstruc-
tion approaches to understand human tissue differentiation,
especially when searching beyond transcription factors.
The epidermis is an excellent model for the application of a
network reconstruction approach to discover non-transcription
factor regulators because it is a relatively well characterized tis-
sue with in vitro model systems derived from primary human
cells. The epidermis is comprised of a basal layer of progenitor
cells that give rise to the layers of epidermis that exit the cell
cycle, enucleate, and provide barrier function through expres-
sion of tissue-specific differentiation genes. The transcriptional
master regulator of the epidermis, p63 (Mills et al., 1999; Truong
et al., 2006; Yang et al., 1999), targets key genes including
ZNF750 (Boxer et al., 2014; Sen et al., 2012) andMAF/MAFB (Lo-
pez-Pajares et al., 2015). Other transcription factors implicatedevier Inc.
in the regulation of epidermal differentiation include KLF4 (Patel
et al., 2006; Segre et al., 1999), GRHL3 (Hopkin et al., 2012; Yu
et al., 2006), and OVOL1 (Teng et al., 2007). Recent work gener-
ated kinetic gene expression data in the regeneration of differen-
tiated epidermal tissue (Lopez-Pajares et al., 2015). The ability to
use this type of kinetic data in a model with well-characterized
positive controls makes it an ideal system for applying network
reconstruction approaches to discover new regulators.
Here, we develop and apply proximity analysis to network
reconstruction during the process of epidermal differentiation.
Analyzing a time course of gene expression during differentiation
generated a network of strongly connected genes, including
those with known roles in differentiation as well as novel candi-
date regulators. A top hit, MPZL3, is highly induced in the
process of epidermal differentiation and downregulated in
cutaneous squamous cell carcinoma. MPZL3 was found to
be essential for epidermal differentiation. Its expression was
controlled by several known transcriptional regulators of differ-
entiation, including p63, ZNF750, KLF4, and RCOR1. Live-cell
vicinal protein labeling followed by mass spectrometry demon-
strated that MPZL3 primarily interacts with mitochondrial pro-
teins, with mitochondrial localization confirmed by electron
microscopy. Among MPZL3-interacting proteins was FDXR, a
mitochondrial enzyme that catalyzes the reduction of ferredoxin.
We observed that FDXR is also required for normal epidermal dif-
ferentiation, and its ectopic expression is capable of rescuing the
differentiation defects of MPZL3 depletion. FDXR, which had
been previously characterized as necessary for ROS-mediated
apoptosis, was found to control epidermal cell ROS levels in
concert with MPZL3, with both proteins mediating ROS-medi-
ated epidermal differentiation. MPZL3 and FDXR action in
differentiation is contingent upon FDXR’s enzymatic ability,
demonstrating an intricate role of mitochondrial-based proteins
in epidermal differentiation. Taken together, these data develop
a new network construction approach to identify an essential




To identify regulators of genomic expression in eukaryotes, we
designed proximity analysis, a network-based approach that
implements topological constraints on a correlation-based
network. Extensive descriptions of networks in yeast, protein-
protein interaction networks, co-expression networks, and
metabolic networks have been characterized by a scale-free,
small-world network topology (Hughes et al., 2000; Ravasz
et al., 2002; Tong et al., 2004; van Noort et al., 2004; Yook
et al., 2004). Proximity analysis uses rank-ordered gene expres-
sion data followed by the generation of a Pearson correlation
matrix for every pair of expressed genes (Figure S1A). Using
this correlation value as a weight, nodes are preferentially con-
nected to a random seed network, with the nodes with more
connections being more likely to gain additional connections
(Figure S1B). Each of the edges generated by each simulation
is given a probability, and after thousands of simulations, edges
with the highest probabilities of inclusion are used for down-
stream analyses. The hypothesis behind these topological con-Developmestraints is that by simulating the preferential attachment models
that have been described to result in scale-free networks (Bara-
basi and Albert, 1999), the relationships between genes that are
biologically related will be highlighted by higher probabilities
within this network. We first optimized proximity analysis for
various input parameters on a series of in silico networks gener-
ated by DreamNetWeaver (Schaffter et al., 2011) (Figure S1C).
We used proximity analysis to analyze the Saccharomyces cer-
evisiae expression data provided to the DREAM5 network chal-
lenge (Table S1) and compared our output to the top-performing
algorithms that have generated networks from this data (Feizi
et al., 2013; Marbach et al., 2012). Because of our interest in
identifying non-transcription factor regulators, we used an alter-
native evaluation metric to the binding site derived metrics used
in the DREAM5 challenge. Using validated gene ontology (GO)
classifications, a frequently used conservative network valida-
tion metric (Chagoyen and Pazos, 2010), proximity analysis out-
performed the other examined algorithms in both the number
and fraction of edges belonging to the same GO term (Fig-
ure S1D). We additionally noted that while all algorithms exam-
ined had an average local clustering coefficient characteristic
of a small-world network and a power law degree distribution
characteristic of a scale-free network topology (Figure S1E),
proximity analysis was the most small-world (Figure S1F) with
the smallest residual when compared to a perfect power law dis-
tribution (Figure S1G). These data suggest that in a eukaryotic
system, proximity analysis may be well-suited to reconstruct a
biologically relevant scale-free, small-world network.
MPZL3 Is a Highly Connected Hub in Epidermis
We applied proximity analysis to time course expression data of
the process of epidermal differentiation in both confluent differ-
entiation culture conditions as well as an organotypic model of
the skin (Table S2) (Kretz et al., 2013; Kretz et al., 2012; Lopez-
Pajares et al., 2015). To identify genes of interest, we ranked
genes in the resulting network by the extent of their small-world
interaction profile and highlighted genes of potential disease
relevance by weighting these hubs by the degree of their change
in cutaneous squamous cell carcinoma (cSCC) expression data-
sets (Arron et al., 2011) (Figure 1A), generating a dynamic hub
score for the most differentially expressed genes (Table S3).
We chose this filter for disease relevance because cSCC is a dis-
ease characterized by a loss of differentiation (Kwa et al., 1992;
Ratushny et al., 2012; Rowe et al., 1992) and candidates high-
lighted by this filter were more likely to also be of interest in the
study of cSCC or other differentiation-relevant malignancies in
the future. The resulting network of epidermal differentiation
had the expected scale-free, small-world topology, with many
edges classified in the same GO term (Figure 1B; Figures S2A–
S2D). GO term analysis of the top 500 most connected genes
from proximity analysis highlighted biological processes related
to epidermal differentiation (Figure 1C), and nearly all transcrip-
tion factors known to regulate epidermal differentiation scored
in the top 10% of all scored nodes (Figure S2E), indicating that
proximity analysis successfully highlighted known regulators of
interest.
The top dynamic hub scoring genes from proximity analysis
highlighted known regulators of differentiation, OVOL1 and
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Figure 1. Proximity Analysis Identifies MPZL3 as a Highly Connected Hub in an Epidermal Differentiation Network
(A) Proximity analysis workflow consists of a correlation matrix generation that uses topological constraints of scale-free, small-world networks to identify genes
that are highly connected, and subsequently cSCC data are used to highlight potential regulators of differentiation.
(B) Network depiction of top 10,000 edges from the network.
(C) Gene ontology terms for the 500 most connected genes in the differentiation network.
(D) Top six candidates that emerge from proximity analysis and their characteristics in terms of dynamic hub score, known function, and disease relevance.
(E) Expression of MPZL3 in differentiation datasets (n = 14) when compared to subconfluent keratinocytes and in cSCC (n = 21) when compared to matched
normal skin. Mean ± SD is shown.
(F) mRNA levels by qPCR from laser capture microscopy separation of basal and suprabasal layers of the skin.
(G) Immunofluorescent staining of MPZL3 (red) and collagen VII (green) in normal human skin (left) as well as a non-MPZL3 antibody control stained with collagen
VII (right). Scale bars, 15 mM.
See also Figures S1 and S2 and Tables S1, S2, and S3.
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of abnormal epidermal differentiation, such as CARD18 (psoria-
sis), CRNN (atopic dermatitis), and ALOX12B (ichthyosis) (Fig-
ure 1D). Of interest in this list of top hits, MPZL3 has no known
mechanism, nor has it been characterized in human disease.
MPZL3 was originally identified via its R99Q mutation in a rough
coat (rc) mouse, characterized by a rough coat, hair loss, ulcer-
ations in the skin, and enlarged sebaceous glands (Cao et al.,
2007). MPZL3 knockout mice recapitulated this phenotype and
additionally exhibited parakeratosis and increased dermal thick-
ness (Leiva et al., 2014) as well as decreased body weight and
lower levels of blood glucose compared towild-type or heterozy-
gous counterparts (Czyzyk et al., 2013). These phenotypes
suggest an important role for MPZL3 in the skin as well as sys-
temically. MPZL3 is highly induced over the course of differenti-
ation and downregulated in cSCC (Figure 1E; Figures S2F and
S2G). Laser capture microscopy of human skin followed by
qPCR showed thatMPZL3mRNA is expressed in the suprabasal
layers of the skin at a similar scale to classical markers of the
spinous and granular layers (Figure 1F), suggesting its transcript
is detectable in a pattern similar to these other epidermal differ-
entiationmarkers. To localize expression of MPZL3 protein in tis-
sue, we generated MPZL3-specific rabbit polyclonal antibodies.
Indirect immunofluorescence of endogenous MPZL3 protein
with these antibodies confirmed MPZL3 protein distribution in
differentiating layers of intact normal human skin (Figure 1G).
MPZL3 is thus a highly connected hub in the proximity-anal-
ysis-generated epidermal differentiation network that is strongly
expressed in differentiating epidermal cells.
MPZL3 Is Required for Normal Epidermal Differentiation
On the basis of its high dynamic hub score in our proximity anal-
ysis screen and its expression increase over the course of differ-
entiation, we tested if MPZL3 is required for normal epidermal
differentiation by reducing its expression with two distinct small
interfering RNAs (siRNAs) in human organotypic epidermal tis-
sue. This setting recapitulates the three-dimensional tissue
architecture, gene expression, and protein localization charac-
teristic of normal epidermis (Lopez-Pajares et al., 2015).
MPZL3-depleted epidermal tissue failed to normally express
early (K1 and K10) and late (LOR, TGM1) differentiation proteins
in suprabasal epidermal layers (Figure 2A; Figure S2H), and this
lack of differentiation gene inductionwas further confirmed at the
transcript level for these and additional markers of differentiation
(Figure 2B). To test if MPZL3 could itself drive epidermal differen-
tiation, we expressed it in undifferentiated keratinocyte progen-
itor populations. In this context, MPZL3 was capable of inducing
both early and late differentiation genes (Figure S2I). MPZL3 is
therefore necessary and sufficient for induction of key epidermal
differentiation genes.
MPZL3 contains a predicted signal sequence at the amino-ter-
minal region of the protein followed by an IGV-like domain that
contains the ortholog of the R99Q mutation previously identified
in the rc mouse (Cao et al., 2007). MPZL3 also contains a trans-
membrane (TM) domain and a carboxy-terminal low complexity
(LC) region (Racz et al., 2009). To identify the domains of MPZL3
that are functional in epidermal differentiation, we performed
rescue of MPZL3 knockdown with full-length wild-type MPZL3
as well as the MPZL3 R99Q mutant and several MPZL3 trunca-
tion mutants. Full-length MPZL3 largely restored expression ofDevelopmedifferentiation marker genes in MPZL3 knockdown cells. In
contrast, MPZL3 R99Q and truncation mutants lacking the TM-
LC domain did not rescue differentiation. Interestingly, the TM-
LC region rescued the differentiation defects ofMPZL3 depletion
(Figure 2C), suggesting it may mediate key functions of the
MPZL3 protein in differentiation. MPZL3’s carboxy-terminal LC
region is therefore required for MPZL3 action in epidermal
differentiation.
To characterize the spectrum of genes whose expression is
influenced by MPZL3, we performed RNA sequencing on differ-
entiated keratinocytes that were depleted of MPZL3. MPZL3
loss altered the expression of 520 genes compared to control
(Figure 2D; Table S4), with downregulated genes strongly en-
riched for GO terms related to epidermal differentiation (Fig-
ure 2E). The genes regulated by MPZL3 had significantly more
small-world connections than an equally sized random set of
genes (Figure S2J). Comparison of this downregulated gene
signature to known regulators of differentiation indicated signif-
icant overlap with four transcription factors—KLF4, p63,
ZNF750, and RCOR1—but not with a negative control ANCR, a
long non-coding RNA that is required for maintenance of the pro-
genitor state (Boxer et al., 2014; Kretz et al., 2012; Truong et al.,
2006) (Figure 2F). Analysis of the profiles of KLF4, p63, ZNF750,
and RCOR1 interestingly indicated that these genes regulate
the transcript levels of MPZL3, in contrast to 54 other known dif-
ferentiation regulators who displayed less impact on MPZL3
expression, including MAF/MAFB, STAU1, GRHL3, TINCR,
and ANCR (Figure 2G). Chromatin immunoprecipitation (ChIP)
qPCR analysis of a putative regulatory region 12 kb upstream
of the MPZL3 transcription start site, identified from analysis of
prior ChIP sequencing (ChIP-seq) studies of these factors (Boxer
et al., 2014; Sen et al., 2012), indicated that these four transcrip-
tion factors have enriched binding at this locus compared to an
IgG control and a gene desert region (Figure 2H). These data
suggest that MPZL3 is a functionally relevant downstream target
of these transcription factors in epidermal differentiation. We
tested this by determining if enforced MPZL3 expression
rescued the loss of differentiation gene induction caused by
depletion of p63, ZNF750, KLF4, and RCOR1. In each case,
MPZL3 partially rescued loss (Figure 2I; Figures S2K and S2L),
confirming it is a functionally relevant downstream target of
these known regulators of differentiation.
Mitochondrial Localization of MPZL3
To explore the mechanism of MPZL3 action, we generated a
fusion of MPZL3 to the mutated promiscuous biotin ligase
BirA*, which has previously been used to perform an unbiased
interactome analysis (Roux et al., 2012). In this approach, pro-
teins physically proximal to the protein of interest are biotinylated
by BirA* in living cells, purified using streptavidin, then identified
by mass spectrometry (Figure S3A). Using this approach, we
identified 52 proteins proximal to MPZL3 that were not present
in other BirA* fusion protein datasets (Mellacheruvu et al.,
2013) nor in the BirA* control experiment. Unexpectedly, 40
(77%) of the MPZL3 interactome involved proteins localized to
mitochondria (Figure 3A). Several of these proteins are known
either to interact physically with each other or to regulate the
same mitochondrial pathways, suggesting that MPZL3 differen-
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Figure 2. MPZL3 Is Required for Normal Epidermal Differentiation
(A) Knockdown ofMPZL3with two distinct siRNAs in an organotypicmodel of differentiation indicates thatmarkers of differentiation (K1, K10, LOR, TGM1) are not
expressed as highly in MPZL3i samples compared to a control siRNA. Scale bars, 20 mM.
(B) Quantification of transcript levels of a panel of epidermal differentiation markers with either control siRNA or MPZL3 siRNA mediated knockdown (KD). n = 3
biological replicates; mean ± SEM is shown.
(C) Rescue experiments of the MPZL3 KD phenotype was evaluated in the context of forced expression of wild-type MPZL3, MPZL3 R99Q, or two truncated
versions of MPZL3 with siRNAs to KD MPZL3. Values shown are the mean of three biological replications, averaged between two siRNAs.
(D) RNA sequencing was performed on keratinocytes that were subjected to differentiation conditions in culture. The heatmap shows genes that are changed at
least 4-fold in either of the MPZL3 KD conditions compared to control siRNA.
(E) Gene ontology analysis of the genes that are downregulated in the RNA sequencing dataset with MPZL3 KD.
(F) Overlap of the genes that are downregulated with MPZL3 KD with the gene signatures of known regulators of epidermal differentiation. The left column in-
dicates the number of genes involved in the overlap and *** indicates a p value < 0.001 (Fisher’s exact test); ns indicates a non-significant p value.
(G) MPZL3 expression level in datasets with perturbation of known regulators of epidermal differentiation (Boxer et al., 2014; Hopkin et al., 2012; Kretz et al., 2013;
Lopez-Pajares et al., 2015; Truong et al., 2006).
(H) ChIP qPCR analysis of genomic regions surrounding MPZL3 genomic locus indicates known regulators of MPZL3 transcript expression are enriched for
binding in a proximal genomic region compared to an IgG control. n = 2 biological replicates; mean ± SD is shown.
(I) Quantification of transcript levels in heatmap format of a panel of epidermal differentiation markers with the KD of known regulators of epidermal differentiation,
with or without forced expression of MPZL3.
See also Figure S2 and Table S4.proteins, though none of these have yet been described
as important in epidermal differentiation. To further validate
the localization of MPZL3, we performed cell fractionation
(Figure S3B) and electron microscopy in keratinocytes that
confirmed the majority of MPZL3 localizes to the mitochondria
(Figures 3B and 3C). SAINT score analysis, a metric for the likeli-
hood of a true interaction (Choi et al., 2011), indicated that the448 Developmental Cell 35, 444–457, November 23, 2015 ª2015 Elstop 10 interactions were all more than 95% likely to be real inter-
actions, and interestingly these proteins were enriched for mito-
chondrial matrix localization (Figure 3D).
To better understand the role of MPZL3 in mitochondrial
biology, we assayed the mitochondrial morphology of cells
depleted of MPZL3 by siRNA compared to control siRNA



























































Quantitation of MPZL3 

































MPZL3 MPZL3 R99Q IGV-Like-TM TM-LC
siCtrl
G HProximity Ligation Analysis of FDXR with Mutant and WT MPZL3  
IgG IP






































PLA Quantitation of WT and 













Figure 3. MPZL3 Localizes in Mitochondria and Interacts with FDXR
(A) Depiction of MPZL3 proximal proteins identified by mass spectrometry of biotinylated proteins isolated from differentiated cells expressing an MPZL3-BirA*
fusion construct. The 53 proteins shown in this network were detected exclusively in the MPZL3-BirA* expressing cells as opposed to BirA* only expressing cells
and were filtered for proteins that are commonly found in BirA* experiments.
(B) Electron microscopy in keratinocytes expressing an MPZL3 overexpression construct. Antibodies to HA were used to identify MPZL3, and 5-nm gold
conjugate was used for detection. A representative image of a mitochondria dotted with gold particles is shown.
(C) Quantification of observed localization of gold conjugates tagging the expressed MPZL3-FHH protein.
(D) Table representing the top proximal hits from the MPZL3-BirA* tagging experiment indicating number of spectral counts for each hit as well as the
SAINT score.
(E) Proximity ligation analysis with endogenousMPZL3 and FDXR. The signal representing the interaction is shown in red, and nuclei are marked by the blue DAPI
signal. siRNAs targeting either MPZL3 or FDXR ablate the observed signal. Representative images are shown. Scale bar, 7 mM.
(F) Co-immunoprecipitation between MPZL3 and FDXR; 1% of input is shown.
(G) Proximity ligation analysis on HA-tagged constructs of wild-type MPZL3, MPZL3 R99Q, and two truncations of MPZL3 with endogenous FDXR antibody. The
signal representing the interaction is shown in red, and nuclei are marked by the blue DAPI signal. Representative images are shown. Scale bar, 7 mM.
(H) Quantification of the proximity ligation analysis signal shown in (G). n = 3 biological replicates with at least 10 images analyzed per replicate; mean ± SEM
is shown.
See also Figures S3 and S4 and Table S5.significantly smaller mitochondria, though the mitochondrial
membrane potential, as measured by JC-1 aggregation, was
not abolished (Figures S3C–S3F). We additionally stained for
mitochondrial protein, mitofilin, in normal human skin to validate
that mitochondria are abundantly present in layers of the skin
that overlap with MPZL3 expression (Figure S3G). We also per-
formed metabolomics analysis of differentiated keratinocytes
with 5 types of mass spectrometry identifying 621 compoundsDevelopmein these cells. Few of these compounds were changed signifi-
cantly in even one of the siRNA experiments, but those that
were changed were related to pathways including lipid, lipoate,
and fatty acid metabolism (Figures S3H and S3I), which is
consistent with the previously identified role of MPZL3 in organ-
ismal level metabolism changes (Czyzyk et al., 2013).
The most proximal protein to MPZL3 by both spectral counts
and SAINT score was ferredoxin reductase (FDXR), an enzymental Cell 35, 444–457, November 23, 2015 ª2015 Elsevier Inc. 449
that catalyzes the reduction of ferredoxin with an electron from
NADPH and has been studied for its role as a p53 target gene
required for reactive oxygen species (ROS)-mediated apoptosis
via its interaction with Fhit (Hwang et al., 2001; Liu and Chen,
2002; Pichiorri et al., 2009). siRNA mediated depletion of the
next five top mitochondrial hits by SAINT score did not pheno-
copy the MPZL3 differentiation defect (Figure S4A), so we
focused upon FDXR as a functional candidate to explain
MPZL3’s role in epidermal differentiation. FDXR, whose expres-
sion was observed to be generally constant during the course of
differentiation (Figures S4B–S4D), therefore represents a candi-
date partner for MPZL3 function during this process.
To characterize the MPZL3-FDXR interaction, we first used
proximity ligation analysis (PLA) (So¨derberg et al., 2008) to vali-
date the proximal co-localization of FDXR and MPZL3 in
keratinocytes (Figure 3E; Figure S4E). We next validated the
interaction between FDXR and MPZL3 using co-immunoprecip-
itations, with each protein pulling down the other and further
confirming their interaction (Figure 3F). We additionally per-
formed PLA between endogenous FDXR and an HA tagged
version of wild-type MPZL3, MPZL3 R99Q, the IGV-like TM trun-
cation, and a TM-LC truncation of MPZL3. Interestingly, the
functionally active wild-type MPZL3 and TM-LC truncation
yielded detectable interaction signal with FDXR. In contrast,
the non-functional R99QMPZL3 and IGV-like TMMPZL3 trunca-
tion mutants did not (Figures 3G and 3H; Figures S4H and S4I),
indicating that FDXR binding is associated with functional
MPZL3. These findings indicate that MPZL3 protein resides in
mitochondria and raise the possibility of a potentially functional
role for MPZL3 binding to the FDXR mitochondrial protein.
FDXR in Epidermal Differentiation
If FDXR is a functionally important MPZL3-interacting protein
in the latter’s pro-differentiation impacts, then its loss would
also be predicted to impair differentiation. To test this, we
depleted FDXR from organotypic human epidermal tissue and
examined the expression of differentiation genes. FDXR deple-
tion decreased differentiation gene expression, as confirmed at
the protein and mRNA levels (Figures 4A and 4B; Figure S4F).
These results recapitulated MPZL3 loss. To further understand
FDXR’s role in differentiation, we performed RNA sequencing
in the context of FDXR knockdown in keratinocytes undergoing
differentiation induction in vitro. 774 genes were changed, and
overlapping the genes changed with FDXR depletion and those
altered by MPZL3 depletion yielded a significant overlap of 113
genes (p value < 0.05) (Figures 4C and 4D). Analysis of these
genes indicated that they are enriched for GO terms relating to
keratinocyte differentiation (Figure 4E), suggesting that FDXR
may regulate epidermal differentiation in a manner similar to
that of MPZL3. Indeed, similar to MPZL3, ectopic expression
of FDXR in undifferentiated keratinocytes increased the expres-
sion ofmarkers of epidermal differentiation (Figure 4F), indicating
that FDXR is also necessary and sufficient for this process. We
further examined the relationship between MPZL3 and FDXR
by performing a functional rescue experiment with forced
FDXR expression in the context of MPZL3 depletion. FDXR
expression was sufficient to rescue differentiation defects of
MPZL3 loss (Figure 4G), indicating that, in addition to binding
MPZL3, FDXR can compensate for MPZL3 function when450 Developmental Cell 35, 444–457, November 23, 2015 ª2015 ElsFDXR is highly expressed. In contrast, enforced MPZL3 expres-
sion could not rescue the differentiation gene loss seen with
FDXR depletion (Figure S4G), indicating that MPZL3 pro-differ-
entiation impacts depend upon the presence of FDXR. FDXR is
therefore necessary and sufficient to induce differentiation
genes in a manner that appears functionally downstream of
MPZL3.
MPZL3 and FDXR Regulate ROS
We next explored how MPZL3 and FDXR enable epidermal dif-
ferentiation. To do this, we focused on their roles in generating
ROS. A recent study implicated a potential role for mitochondria
in epidermal differentiation via a requirement for intactness of the
mitochondrial electron transport chain and ROS production (Ha-
manaka et al., 2013). Additionally, other prior work had observed
that FDXR influenced ROS-mediated apoptosis in epithelial can-
cer cell lines (Liu and Chen, 2002). We thus tested if the effects of
MPZL3 and FDXR in epidermal differentiation might involve im-
pacts on levels of ROS in epidermal cells. We first validated
that there is indeed an upregulation of ROS in our model of ker-
atinocyte differentiation (Figure 5A). We next noted that deple-
tion of MPZL3 and FDXR, alone or together, decreased the
detectable ROS in these cells (Figure 5B). Moreover, enforced
expression of MPZL3 and FDXR, alone or together, increased
the detectable levels of intracellular ROS (Figure 5C), suggesting
that the observed differentiation phenotypes with depletion or
forced expression of MPZL3/FDXR may indeed be a result of
changes in ROS.
To test this hypothesis, we differentiated keratinocytes in the
context of MPZL3 and FDXR knockdown and treated these cells
with either a DMSO vehicle control or with galactose oxidase
(GAO), an enzyme that exogenously generates ROS within the
cell. Consistent with the hypothesis that MPZL3/FDXR regulate
differentiation through ROS regulation, GAO treatment rescued
the transcript level differentiation defects of MPZL3/FDXR
depletion (Figure 5D; Figure S5A). To further confirm this finding,
undifferentiated cells ectopically expressing MPZL3 and FDXR
were treated with EUK134, a chemical sponge for ROS, to see
if blocking MPZL3/FDXR-induced increase in ROS would block
their pro-differentiation effects. EUK134 reversed the increased
differentiation marker expression driven by enforced expression
of MPZL3 and FDXR (Figures 5E and 5F; Figure S5B). Thus, the
pro-differentiation effects of MPZL3 and FDXR depend on ROS.
Previous work suggested that ROS in the context of epidermal
differentiation may function via modulation of NOTCH signaling,
and based upon the regulation of ROS by MPZL3 and FDXR, we
performed gene set enrichment analysis (GSEA) (Mootha et al.,
2003) on the RNA sequencing profiles of MPZL3 and FDXR (Ha-
manaka et al., 2013). Indeed, these datasets are significantly en-
riched for genes that are transcriptionally regulated by NOTCH
(Figure S5C), and qPCR of selected NOTCH target genes verified
that double knockdown ofMPZL3 and FDXR results in the deple-
tion of several of these targets (Figure S5D).
We furthermore tested the relationship of ROS and epidermal
differentiation by overexpressing SOD1 and SOD2 superoxide
dismutase genes in the context of epidermal differentiation.
Overexpression of these genes reduced ROS levels and the
levels of differentiation marker gene expression (Figures S5E
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Figure 4. FDXR Phenocopies and Rescues MPZL3 Differentiation Defects
(A) Knockdown of FDXR with two distinct siRNAs in human organotypic epidermis indicates that markers of differentiation (K1, K10, LOR, TGM1) are inhibited in
FDXR KD samples compared to control siRNA. Scale bars, 20 mM.
(B) Quantification of transcript levels of a panel of epidermal differentiation markers with either control or FDXR siRNA mediated KD. n = 3 biological replicates;
mean ± SEM is shown.
(C) RNA sequencing was performed on keratinocytes subjected to differentiation conditions in culture. The heatmap shows genes that are changed at least 4-fold
in either of the FDXR KD conditions compared to control siRNA.
(D) Overlap between genes changed with MPZL3 KD or FDXR KD. The overlap of 113 genes is significant with a p value < 0.05, Fisher’s exact test.
(E) Gene ontology analysis of the set of overlapped genes.
(F) Quantitation of transcript levels of a panel of differentiation markers in subconfluent cells with enforced expression of FDXR.
(G) Rescue experiments of the MPZL3 KD phenotype in the context of forced expression of FDXR with siRNAs to KDMPZL3. Quantitation of transcript levels of a
panel of epidermal differentiation markers is shown. n = 3 biological replicates; mean ± SEM is shown.
See also Table S6.differentiated keratinocytes and saw a proportional decrease
in epidermal differentiation gene marker expression with the
decrease of ROS (Figures S5G and S5H). Additionally, the corol-
lary experiment of treating undifferentiated keratinocytes withDevelopmeGAO and titrating the levels of galactose resulted in an increase
of both epidermal differentiation gene expression and ROS (Fig-
ures S5I and S5J). These data agree with previous observations





(legend on next page)
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differentiation via modulation of ROS, a key signaling molecule
required for epidermal differentiation.
We next examined the role of FDXR catalytic activity in this
process. FDXR’s rescue of impaired differentiation due to
MPZL3 depletion, along with overexpressed FDXR’s capacity
to induce differentiation in undifferentiated epidermal cells that
lack significant MPZL3, suggested that FDXR-driven differentia-
tion may require its enzymatic activity and that MPZL3 may help
enhance that activity. To test this possibility, we measured
NADPH, a substrate of FDXR (Figure S6A), from whole-cell
lysates of keratinocytes in differentiation conditions. Active
FDXR catalytic activity should decrease NADPH levels. As ex-
pected, forced expression of FDXR decreased the amount of
NADPH in the cell. Consistent with this, in differentiation condi-
tions where MPZL3 is highly expressed, MPZL3 depletion
increased themeasurable levels of cellular NADPHback to levels
comparable to control as well as FDXR depletion did, consistent
with MPZL3’s impact on FDXR catalytic activity (Figure 6A; Fig-
ures S6B and S6C). Upon depletion of MPZL3 or FDXR in the
context of enforced FDXR expression, ROS levels were also
diminished (Figure S6D). Testing the hypothesis that the relation-
ship between NADPH and ROS is important in the context of
epidermal differentiation, we ectopically expressed NOX5, an
NADPH oxidase protein. This experiment increased the levels
of epidermal differentiation gene expression, lowered the relative
levels of intracellular NADPH, and increased ROS within these
cells (Figures S6E–S6H). These data support the model that
NADPH and ROS are importantly linked in the context of
epidermal differentiation, highlighting the importance of FDXR’s
catalytic activity during this process.
To further interrogate the role of FDXR catalytic activity, we
generated mutants of FDXR lacking residues needed to bind
NADPH and FAD, a cofactor of FDXR (Lambeth and Kamin,
1976; UniProt Consortium, 2015). Each of these mutants dis-
played lower levels of enzymatic activity compared to wild-
typeFDXR, in spite of retaining their binding toMPZL3 (Figure 6B;
Figures S6I and S6J). Unlike wild-type FDXR, none of these mu-
tants were able to induce differentiation gene expression in un-
differentiated keratinocytes (Figure 6C), and the NADPH and
FAD binding mutants also failed to fully rescue full expression
of selected differentiation markers (Figure 6D; Figures S6K and
S6L). These data indicate that FDXR enzymatic activity is
required for its function in differentiation and that its enzymatic
activity is dependent uponMPZL3. Taken together, these obser-
vations are consistent with a model of epidermal differentiationFigure 5. MPZL3 and FDXR Regulate and Are Required for ROS Media
(A) Reactive oxygen species (ROS) levels in differentiating cultured keratinocyte
Hydrogen peroxide (H202) was used as a measurement control. * indicates p < 0
(B) ROS levels with MPZL3 and/or FDXR KD as measured by DCF-DA fluoresce
(C) ROS levels with forced MPZL3 and/or FDXR expression as measured by DCF
is shown.
(D) ROS levels when cells are treated with either DMSO or with GAO as measure
(E) Quantitation of transcript levels of a panel of differentiation markers with KD
galactose oxidase (GAO). n = 3 biological replicates; mean ± SD is shown. * indi
(F) ROS levels when cells are treated with either DMSO or with EUK134 as meas
(G) Quantitation of transcript levels of a panel of differentiation markers with enfor
with EUK134. n = 3 biological replicates; mean ± SD is shown.
(H) Summary heatmap of the ROS rescue experiments.
See also Figure S5.
Developmewhere known dominant regulators of differentiation, including
p63, ZNF750, KLF4, and RCOR1, are necessary to induce
MPZL3 expression, following which MPZL3 binds to stably ex-
pressed FDXR, promoting FDXR’s enzymatic activity to generate
ROS-driven epidermal differentiation (Figure 6E).
DISCUSSION
Here, we present a new network approach—proximity anal-
ysis—that is unbiased toward protein subcellular location and
that discovered new regulatory mechanisms for mitochondrial
proteins in epidermal differentiation. Proximity analysis uses to-
pological constraints to identify regulators in eukaryotic systems
by using biologically influenced network simulation to generate a
probabilistic network that reconstructs network topology, high-
lighting highly connected nodes. Using proximity analysis, we
identified MPZL3 as a candidate regulator of epidermal differen-
tiation. MPZL3 is required for normal epidermal differentiation
and is downstream of known transcription factor regulators of
epidermal differentiation. Mass spectrometry identified that the
majority of proteins proximal to MPZL3 are those known to
reside in the mitochondria, with electron microscopy validating
MPZL3’s mitochondrial localization. Interaction with the top hit,
the FDXR mitochondrial protein, was confirmed by PLA and
co-immunoprecipitation, and FDXR was also discovered to be
essential for epidermal differentiation. FDXR rescues the differ-
entiation defects seen with MPZL3 depletion, and MPZL3 and
FDXR together induce ROS, which is required for epidermal
differentiation.
Previous work on network-based approaches to understand-
ing somatic tissue differentiation has primarily focused upon
transcription factors (Suzuki et al., 2009; Yosef et al., 2013).
Understanding transcriptional regulation of somatic tissue differ-
entiation is essential; however, the ability to detect non-tran-
scription factor regulators is an exciting challenge as the frontiers
of understanding biological regulation expand to other parts of
the cell. The mitochondria has become a fascinating example
of how non-transcription factor regulation can happen in a
myriad of ways, regulating key cellular functions such as
apoptosis and metabolism (Kasahara and Scorrano, 2014). The
epidermis is a tractable setting to seek a better understanding
of this regulation as recent work has extensively explored the
transcriptional modules and signatures that are characteristic
of the phases of differentiation (Lopez-Pajares et al., 2015),
and smaller scale attempts have been made at exploring theted Differentiation
s as measured by 20,70-dichlorofluorescin diacetate (DCF-DA) fluorescence.
.05. n = 5 biological replicates; mean ± SEM is shown.
nce. * indicates p < 0.05. n = 5 biological replicates; mean ± SEM is shown.
-DA fluorescence. * indicates p < 0.05. n = 5 biological replicates; mean ± SEM
d by DCF-DA fluorescence.
of MPZL3 and FDXR by siRNA with either DMSO treatment or treatment with
cates p < 0.05, ** indicates p < 0.01, and *** indicates p < 0.001.
ured by DCF-DA fluorescence.
ced expression of MPZL3 and FDXR with either DMSO treatment or treatment
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Figure 6. FDXR Enzymatic Activity Is Required for Its Role in Differentiation
(A) Relative amount of NADPH as measured by fluorescence compared to differentiated keratinocytes treated with empty vector (EV). n = 3 biological replicates;
mean ± SEM is shown.
(B) Relative amount of NADPH asmeasured by fluorescence compared to differentiated keratinocytes treatedwith EV.Mutant FDXR constructsmarked in red are
predicted to perturb NADPH binding by FDXR, and those in blue are predicted to perturb FAD binding by FDXR. n = 3 biological replicates; mean ± SEM is shown.
(C) Quantitation of transcript levels of a panel of differentiation markers in subconfluent keratinocytes subjected to forced expression of wild-type ormutant FDXR
constructs relative to EV. n = 3 biological replicates; mean ± SEM is shown.
(D) Rescue experiments of the MPZL3 KD phenotype were evaluated in the context of forced expression of FDXR or FDXR mutants with siRNAs to KD MPZL3.
Quantitation of transcript levels of a panel of epidermal differentiation markers is shown in heatmap format. n = 3 biological replicates; mean ± SD is shown.
(E) Model of transcriptional regulation of MPZL3 by known regulators of epidermal differentiation, followed by mitochondrial localization, interaction with FDXR,
and joint regulation of ROS required for terminal epidermal differentiation.
See also Figure S6.spatiotemporal relationships that are key in regulating the
epidermis from a network-based perspective (Grabe et al.,
2007). Proximity analysis highlighted many known regulators of
epidermal differentiation, as well as a host of previously unchar-
acterized new candidates (Tables S2 and S3) that could be
explored to better understand various aspects of somatic tissue
differentiation.
We also used a filter of opposite expression patterns in cSCC
to generate the dynamic hub score that ranked proteins of inter-
est. Given that this filter, alongside the parameters of small-world
interaction connectedness, highlighted several genes with454 Developmental Cell 35, 444–457, November 23, 2015 ª2015 Elsknown roles in epidermal disease, this raises the possibility
that other candidates from this list, including MPZL3 itself, may
have a role in the pathogenesis of cSCC or other epithelial
diseases. Indeed, MPZL3 is less expressed in cSCC than in un-
differentiated subconfluent keratinocytes, and given its require-
ment for complete terminal differentiation, further work may
elucidate a mechanism of MPZL3 action in carcinogenesis.
To validate the efficacy of proximity analysis and to better
characterize the process of epidermal differentiation, we showed
that MPZL3 is necessary for normal epidermal differentiation
gene induction. The discovery that MPZL3 localizes to theevier Inc.
mitochondria is consistent with the phenotypes that have been
observed in MPZL3 mutant and knockout mice, which
display lower body weight, even in the context of high fat diets,
as well as lower blood glucose levels (Cao et al., 2007; Czyzyk
et al., 2013; Leiva et al., 2014). These previous observations,
paired with its localization determined here, suggest MPZL3
may have other important biological roles that would be of
interest to explore in future work. In addition to binding
FDXR, our mass spectrometry experiment identified a number
of other mitochondrial proteins that are proximal to MPZL3,
some of which have already been described as related to
one another metabolically or physically and are excellent candi-
dates to pursue in better characterizing additional MPZL3
functions.
MPZL3 and FDXRwere found to bind one another and to regu-
late ROS, with both MPZL3-FDXR binding and ROS induction
appearing necessary for normal differentiation. It is possible
that ROS plays a role in feedforward regulation that is necessary
to complete this process in a manner that is analogous to its role
in p53 and FDXR-mediated apoptosis (Liu and Chen, 2002).
Given that FDXR enzymatic function appears to be required for
its functions in differentiation, this suggests that FDXR enzymatic
use of its substrate NADPH may prevent its quenching of ROS,
allowing its accumulation and promotion of differentiation. In
this context, it is unclear how MPZL3 enables FDXR activity. It
is possible that MPZL3, as a transmembrane protein, acts as
an anchor to bind FDXR and increase its local concentration
within the mitochondria to enhance its catalytic activity. Consis-
tent with this possibility are the positive impacts on differentia-
tion of enforced FDXR expression. The increasing body of
literature suggesting that ROS is tightly regulated to control
cell state transitions (Barbieri et al., 2003; Tormos et al., 2011;
Zhang et al., 2013) suggests that there may be similar mecha-
nisms regulating the expression of other proteins impacting
ROS production, a possibility that warrants further study. Addi-
tional assays including examination of mitochondrial mor-
phology and metabolomics suggest that there are roles for
MPZL3 beyond the regulation of ROS described here and may
be an interesting avenue for future investigation of MPZL3 and
mitochondria in epithelial tissue differentiation.EXPERIMENTAL PROCEDURES
The Supplemental Experimental Procedures section, which includes addi-
tional experimental procedures, siRNA sequences, and qPCR primer se-
quences, is available online.
Proximity Analysis
Proximity analysis begins with isolating expressed transcripts in the sample of
interest and rank ordering them from 0 to 1 with an even distribution across the
rangewithin each dataset. Next, the Pearson correlation is calculated between
all gene pairs. Finally, using this correlation matrix as the input for topological
constraints, with optimized metrics based upon DreamNetWeaver in silico
simulations, a random seed network is generated and nodes are added to
this seed network if the absolute value of the correlation between the nodes
being connected is greater than 0.5. This process continues until maximum
limits have been met or all nodes have been tested, and it is iterated 10,000
times to generate a final probability for any edge that was considered. A simpli-
fied version of this iteration step was derived to minimize computational time
and both produced similar results; both versions are available online. Proximity
analysis was performed on S. cerevisiae data from the DREAM5 network chal-Developmelenge and compared to networks based upon the supplemental material of
Marbach et al. (2012). GO term annotations used for scoring algorithms was
downloaded from the Saccharomyces Genome Database (Cherry et al.,
2012). Analysis for epidermal differentiation was performed on data from the
GEO repository (GEO: GSE52651, GSE58161, and GSE35468) as well as a
new microarray 7-day time course of keratinocytes seeded at confluence
with calcium. For this analysis, prior to the rank ordering step of analysis, the
fold change of each gene was calculated between the dataset being analyzed
and the corresponding undifferentiated keratinocyte control. Clustering coef-
ficients were calculated locally based upon the metrics previously described
(Watts and Strogatz, 1998). Scripts used for proximity analysis and related
analyses are freely available for download at http://khavarilab.stanford.edu/
tools-1/#tools.
Dynamic Hub Score
The dynamic hub score was calculated from the local connectivity for
each node in the network, as measured by the number of ‘‘triangles’’ it was
involved in, of any size. This triangle number was weighted by the probability
of the interactions assayed and finally weighted by the degree of inverse
expression change observed in cSCC data (Arron et al., 2011). The top 100
scores are provided in Table S3, excluding any genes not expressed in the
cSCC dataset.
Cell Culture
Primary human keratinocytes were isolated from fresh, surgically discarded
neonatal foreskin. Keratinocytes were grown in Keratinocyte-SFM and
Medium 154 (Life Technologies) in equal proportions with included supple-
ments. Differentiation conditions consist of keratinocytes seeded to full conflu-
ence with 1.2 mM calcium for 3 days. 293T cells were grown in DMEM with
10% fetal bovine serum. Organotypic culture was performed as previously
described (Truong et al., 2006).
RNA Sequencing and Analysis
RNA sequencing libraries were prepared with TruSeqv2 library preparation kit
(Illumina) and sequenced with the Illumina HiSeq platform using 101-bp
paired-end sequencing. Alignment was performedwith TopHat2, and Cuffdiff2
was used to call differential gene expression.
Metabolomics
Metabolomics analysis was performed in differentiated keratinocytes treated
with either control siRNA or independent siRNAs against MPZL3. These exper-
iments were performed on five biological replicates and were conducted by
Metabolon. Five mass spectrometry methods, including ultra performance
liquid chromatography-mass spectrometry (UPLC-MS), positive and negative
ionization LC-MS, liquid chromatography polar mass spectrometry (LC-polar-
MS), and gas chromatography-mass spectrometry (GC-MS), were used to
identify 621 compounds in these keratinocyte cells. The complete dataset is
included in Table S5.
Statistical Methods
All graphs with error bars are shown with either the standard deviation or stan-
dard error of the mean as indicated in the figure legends. The Student’s t test
was used to calculate significance, unless otherwise indicated in the figure
legend. Metabolomics statistics were performed using a one-way ANOVA
analysis and were performed by Metabolon.
ACCESSION NUMBERS
The RNA sequencing andmicroarray data from this work have been deposited
in the Sequencing Read Archive with accession number PRJNA285272.
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